APPLIED DNA SCIENCES INC (APDN)
US03815U3005 - Common Stock
| TTM (2023-12-31) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -7.32M | -10.02M | -8.27M | -14.28M | -13.03M | |||
| Depreciation Amortization | 1.32M | 1.36M | 1.29M | 840.00K | 290.00K | |||
| Change In Working Capital | 3.13M | 2.45M | 950.00K | -3.62M | 530.00K | |||
| Interest Paid | 0.00 | 0.00 | 0.00 | 30.00K | 50.00K | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | -4.74M | -3.64K | -2.95M | 3.66M | 1.07M | |||
| OPERATING CASH FLOW | -7.60M | -6.22M | -8.98M | -13.39M | -11.14M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -1.14M | -490.00K | -2.55M | -1.06M | |||
| Other Investing Activity | N/A | 45.00K | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | -1.10M | -490.00K | -2.55M | -1.06M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -1.67M | 740.00K | |||
| Stock Issued/Repurchased | N/A | 0.00 | 18.13M | 16.37M | 18.70M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | N/A | 0.00 | 18.13M | 14.70M | 19.43M | |||
| CHANGE IN CASH | -8.77M | -7.31M | 8.66M | -1.24M | 7.23M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.60M | -6.22M | -8.98M | -13.39M | -11.14M | |||
| Capital Expenditure | N/A | -1.14M | -490.00K | -2.55M | -1.06M | |||
| FREE CASH FLOW | -8.74M | -7.36M | -9.47M | -15.94M | -12.20M | |||
All data in USD